Anavex Life Sciences Corp.: Exhibit 10.2 - Filed by newsfilecorp.com






1/3 

CONTRACT LEASE AGREEMENT

BETWEEN 

Anavex Life Sciences Corp. a State of Nevada registered public
company, having its office, at 2 Place du Port CH 1204 Geneva Switzerland.


  Hereinafter referred to as “Anavex”.

AND 

Euro Genet Labs SA a private company registered in Greece with
its head office at 27 Marathonos Avenue, 15351 Pallini, Athens, Greece.

Hereinafter referred to as “Euro Genet ”. 

Hereinafter collectively referred to as the “Parties”. 

WHEREAS:

	1. 	
      Anavex entered into a contact lease agreement with Euro
      Genet Labs SA dated September 13, 2007 wishes to modify the terms of the
      agreement with Euro Genet Labs.

	 	 
	2. 	
      Euro Genet Labs SA is a drug development laboratory with
      11.000 Square Footage of research facilities, to provide Anavex carries
      out its drug research and development program.

	 	 
	3. 	
      Parties agree to execute this Lease Agreement in
      accordance with the terms and conditions herein
  contained.



THEREFORE THE FOLLOWING IS ESTABLISHED AND
AGREED: 

1: APPOINTMENT 

	 	(a) 	
      Subject to the terms and conditions hereof, Anavex
      designates and appoints Euro Genet to provide the Facilities as
      follows:




	1.1 	
      Euro Genet hereby accepts the aforesaid appointment with
      Anavex that it shall provide the Services in accordance with the terms
      hereof.



2: TERM 

	2.1 	
      The term of this Agreement is effective February 1,2010
      and is for Three (3) years unless either party hereto gives to the other
      Three(3) months prior written notice of its intention not to further renew
      this Agreement in which event this Agreement shall be terminated at the
      end of such term.







2/3 

3: FACILITIES 

	3.1 	
      Facilities and equipment provided by Euro Genet Labs SA
      will include items as detailed in “Schedule A” as
  attached.



4: FEE 

	4.1 	
      In consideration for the lease of the research facilities
      Anavex shall pay to Euro Genet a fixed monthly fee US$125,000.00. Such
      amount shall be reviewed on an annual basis and is subject to change
      providing such change is justified and approved by the parties.

	 	 
	4.2 	
      Payment as agreed will be made in cash to a bank account
      of Euro Genet Labs SA Such payment will be made on the first business day
      of each month.



5: TERMINATION 

	
      5.1: 
	
      Anavex reserves the right to terminate this agreement at
      any time by giving three (3) months written notice to Euro Genet Labs SA.
      Such notice to be delivered by courier to the address below.
  



6: RESULTS 

	6.1 	
      All Patents arising from the drug molecules which
      are owned (patented) by Anavex is the exclusive property of Anavex Life
      Sciences

	 	 
	6.3 	
      Euro Genet will not be entitled to proceed to any
      publications related to the Anavex project without the prior and written
      consent of the company, despite the termination or expiration of this
      Agreement.



7: MISCELLANEOUS

	7.1 	This Agreement cannot be modified
      any amendment must be signed by an authorized representative of each
      Party. 



	7.2 	
      All notices and other communications required hereunder
      shall be in writing and shall be delivered personally or by telecopier to
      the parties hereto at the following addresses:



ANAVEX: 
2, Place du Port CH-1204

Geneva, Switzerland 
Fax: +41 22 71 65 319 


Euro Genet Labs SA 27 Marathonos
Avenue, 15251 Pallini 
Athens, Greece 
Fax: +30 210 603 4028 





3/3 

Any such notice or other communication shall be deemed to have
been given and received on the day on which it was so delivered or transmitted,
and if not a business day, then on the business day next following the day of
delivery. Either party may change its address for notice in the aforesaid
manner. 

8: DISPUTES 

	8.1. 	
      All disputes arising in connection with the
      interpretation and/or the execution of this Agreement shall be governed by
      US law in the State of Nevada.



 

IN WITNESS WHEREOF the parties hereto have executed this
Agreement as of the date first above written. 

	For: Anavex Life Sciences Corp. 	For: Euro Genet Labs S.A 
	 	 
	Name : Harvey Lalach 	Name : Dimitrios K. 
      Foussekis          T 
	 	 
	  	Title : Vice President 
	 	 
	Date : February 1, 2010 	Date : February 1, 2010 
	 	 
	Signature : 	Signature :